Results 311 to 320 of about 572,501 (357)
Some of the next articles are maybe not open access.
Current Opinion in Oncology, 2003
This article reviews recent advances in the diagnosis and management of bladder cancer.Bladder cancer is a significant cause of morbidity and mortality. Recent research has attempted to improve the care of patients with this disease. Evidence suggests that bacillus Calmette-Guerin is the most effective intravesical therapy for the treatment of ...
Lester S, Borden +2 more
openaire +4 more sources
This article reviews recent advances in the diagnosis and management of bladder cancer.Bladder cancer is a significant cause of morbidity and mortality. Recent research has attempted to improve the care of patients with this disease. Evidence suggests that bacillus Calmette-Guerin is the most effective intravesical therapy for the treatment of ...
Lester S, Borden +2 more
openaire +4 more sources
Current Opinion in Oncology, 2006
This article will review the diagnosis and management of bladder cancer at each stage, from superficial to metastatic disease with an emphasis on recent developments over the last year.Bacille Calmette-Guerin is the most effective therapy for carcinoma in situ.
Eric S, Gwynn, Peter E, Clark
openaire +2 more sources
This article will review the diagnosis and management of bladder cancer at each stage, from superficial to metastatic disease with an emphasis on recent developments over the last year.Bacille Calmette-Guerin is the most effective therapy for carcinoma in situ.
Eric S, Gwynn, Peter E, Clark
openaire +2 more sources
Critical Reviews in Oncology/Hematology, 2002
Bladder cancer is the second most frequent tumour of the urogenital tract. Tobacco smoke has been shown to increase the risk of bladder cancer two- to fivefold as well as the exposure to metabolites of aniline dyes and other aromatic amines. Seventy-five per cent of bladder cancers are superficial at initial presentation, limited to the mucosa ...
de Braud F +6 more
openaire +5 more sources
Bladder cancer is the second most frequent tumour of the urogenital tract. Tobacco smoke has been shown to increase the risk of bladder cancer two- to fivefold as well as the exposure to metabolites of aniline dyes and other aromatic amines. Seventy-five per cent of bladder cancers are superficial at initial presentation, limited to the mucosa ...
de Braud F +6 more
openaire +5 more sources
Current Opinion in Oncology, 2000
There is a need for the development of reliable tumor markers in bladder cancer. A number of studies this past year focused on the evaluation of urinary markers that hold promise as noninvasive adjuncts to traditional diagnostic or surveillance techniques, principally urinary cytology and cystoscopy.
H, Ozen, M C, Hall
openaire +2 more sources
There is a need for the development of reliable tumor markers in bladder cancer. A number of studies this past year focused on the evaluation of urinary markers that hold promise as noninvasive adjuncts to traditional diagnostic or surveillance techniques, principally urinary cytology and cystoscopy.
H, Ozen, M C, Hall
openaire +2 more sources
Current Opinion in Oncology, 1990
Bladder cancer is largely a preventable disease; epidemiologic studies indicate that the majority of cases occur as a result of cigarette smoking or occupational exposures. The impact of screening high-risk populations is uncertain, but prompt and early diagnosis is essential for optimal therapeutic results.
openaire +4 more sources
Bladder cancer is largely a preventable disease; epidemiologic studies indicate that the majority of cases occur as a result of cigarette smoking or occupational exposures. The impact of screening high-risk populations is uncertain, but prompt and early diagnosis is essential for optimal therapeutic results.
openaire +4 more sources
The Lancet, 2016
Bladder cancer is a complex disease associated with high morbidity and mortality rates if not treated optimally. Awareness of haematuria as the major presenting symptom is paramount, and early diagnosis with individualised treatment and follow-up is the key to a successful outcome.
Ashish M, Kamat +8 more
openaire +2 more sources
Bladder cancer is a complex disease associated with high morbidity and mortality rates if not treated optimally. Awareness of haematuria as the major presenting symptom is paramount, and early diagnosis with individualised treatment and follow-up is the key to a successful outcome.
Ashish M, Kamat +8 more
openaire +2 more sources
Current Opinion in Oncology, 2007
This article reviews the diagnosis and management of bladder cancer with an emphasis on studies and developments over the past year.Cystoscopy remains the mainstay in the detection and surveillance of bladder cancer, though efforts continue in the development of urinary bladder cancer markers.
openaire +2 more sources
This article reviews the diagnosis and management of bladder cancer with an emphasis on studies and developments over the past year.Cystoscopy remains the mainstay in the detection and surveillance of bladder cancer, though efforts continue in the development of urinary bladder cancer markers.
openaire +2 more sources
Current Opinion in Oncology, 1992
In the search for sensitive and specific tumor markers for bladder carcinoma, expression of various oncogenes and gene products (such as c-erb B-2, p53) and epidermal growth factor receptor merits particular attention. Although the results are not yet conclusive, important predictive markers are about to emerge from ongoing studies in this field ...
openaire +6 more sources
In the search for sensitive and specific tumor markers for bladder carcinoma, expression of various oncogenes and gene products (such as c-erb B-2, p53) and epidermal growth factor receptor merits particular attention. Although the results are not yet conclusive, important predictive markers are about to emerge from ongoing studies in this field ...
openaire +6 more sources
Urologia Journal, 2020
Until recently, the treatment of bladder cancer, for several years, was limited to surgery and to immunotherapy or chemotherapy. Currently, the extensive analysis of molecular alterations has led to novel treatment approaches. The advent of polymerase chain reaction and genomic hybridization techniques has allowed to investigate alterations involved ...
Siracusano, Salvatore +2 more
openaire +3 more sources
Until recently, the treatment of bladder cancer, for several years, was limited to surgery and to immunotherapy or chemotherapy. Currently, the extensive analysis of molecular alterations has led to novel treatment approaches. The advent of polymerase chain reaction and genomic hybridization techniques has allowed to investigate alterations involved ...
Siracusano, Salvatore +2 more
openaire +3 more sources
International Journal of Urology, 2005
Abstract A characteristic clinical course of a patient with micropapillary bladder cancer, a rare histological variant with high metastatic potential, is presented. An 80‐year‐old woman had locally advanced high‐grade bladder cancer with a focal micropapillary variant identified which was treated with intra‐arterial chemotherapy with radiation therapy.
Koji, Nishizawa +5 more
openaire +2 more sources
Abstract A characteristic clinical course of a patient with micropapillary bladder cancer, a rare histological variant with high metastatic potential, is presented. An 80‐year‐old woman had locally advanced high‐grade bladder cancer with a focal micropapillary variant identified which was treated with intra‐arterial chemotherapy with radiation therapy.
Koji, Nishizawa +5 more
openaire +2 more sources